ArriVent BioPharma (AVBP) Treasury Shares (2023)

ArriVent BioPharma's (AVBP) quarterly Treasury Shares came in at $7387.0 in Q4 2023, up 200.0% quarter-over-quarter from -$7387.0 in Q2 2023.

ArriVent BioPharma (AVBP) Treasury Shares (2023) Analysis & Trends

ArriVent BioPharma has disclosed Treasury Shares across 1 years of filings, most recently posting $7387.0 for Q4 2023.

Treasury Shares for Q4 2023 came in at $7387.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $7387.0 (changed N/A YoY), and the FY2023 annual result was $7387.0, changed N/A from the prior year.
Treasury Shares came in at $7387.0 for Q4 2023 at ArriVent BioPharma, up from -$7387.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $7387.0 in Q4 2023 to a low of -$7387.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	700,000.00
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	ArriVent BioPharma	1.37 Bn	1.37 Bn	-	-

Download Data